Internal Medicine/Cardiology

 

Prakash Deedwania, MD

Professor of Medicine, UCSF 
Professor of Medicine, Stanford University

 

 

 

 

 

 


 

 

  Medical School University of Rajasthan, Jaipur, India
 

Residency:

VA Medical Center, Bronx /Mt. Sinai School of Medicine, New York
  Fellowship: University of Illinois
  Board Certified: National Board of Medical Examiners
American Board of Internal Medicine
American Board of Internal Medicine, Cardiology
  Awards and
Recognition:
  1. Best Doctors in America 2009, 2010, 2011, 2012, 2013,   2014, 2015, 2016
  2. Best Cardiologist in America 2009, 2010, 2011, 2012, 2013. 2014, 2015, 2016
  3. Honorary Fellowship Indian College of Cardiology
  4. Distinguished Service Award Cardiology Society of India 
      

 

     
  Publications: well over 200, including:
   

 

 

Mujib M, Rahman AA, Desai RV, Ahmed MI, Feller MA, Aban I, Love TE, White M, Deedwania P, Aronow WS, Fonarow G, Ahmed A. Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves. Am J Cardiol. 2011 Feb 15; 107(4):552-7. PMID: 21185004.


Arsenault BJ, Barter P, DeMicco DA, Bao W, Preston GM, LaRosa JC, Grundy SM, Deedwania P, Greten H, Wenger NK, Shepherd J, Waters DD, Kastelein JJ. Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers. J Am Coll Cardiol. 2011 Jan 4; 57(1):63-9. PMID: 21185503


Ahmed MI, Mujib M, Desai RV, Feller MA, Daniel C, Aban IB, Love TE, Deedwania P, Pitt B, Aronow WS, Ahmed A. Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched study. Int J Cardiol. 2012 Jan 26; 154(2):128-33. PMID: 20947188.


Vijayaraghavan K, Deedwania P. Renin-angiotensin-aldosterone blockade for cardiovascular disease prevention. Cardiol Clin. 2011 Feb; 29(1):137-56. PMID: 21257105


Gupta R, Deedwania P. Interventions for cardiovascular disease prevention. Cardiol Clin. 2011 Feb; 29(1):15-34. PMID: 21257098


Deedwania P. Preface cardiovascular disease prevention: the continuum of primary and secondary prevention. Cardiol Clin. 2011 Feb; 29(1):xi-xiii. PMID: 21257096


Lardizabal JA, Deedwania P. Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular disease. Cardiol Clin. 2011 Feb; 29(1):87-103. PMID: 21257102


Srikanth S, Deedwania P. Primary and secondary prevention strategy for cardiovascular disease in diabetes mellitus. Cardiol Clin. 2011 Feb; 29(1):47-70. PMID: 21257100


Lardizabal JA, Deedwania PC. The anti-ischemic and anti-anginal properties of statins. Curr Atheroscler Rep. 2011 Feb; 13(1):43-50. PMID: 21107759.


Javed U, Deedwania PC, Bhatt DL, Cannon CP, Dai D, Hernandez A, Peterson ED, Fonarow GC. Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospita participating in Get With The Guidelines (GWTG). Am Heart J. 2011 Feb; 161(2):418-424.e1-3. PMID: 21404720


Carbajal EV, Deedwania P. Role of medical versus interventional strategies to prevent coronary events in patients with stable coronary artery disease. Cardiol Clin. 2011 Feb; 29(1):157-65. PMID: 21257106


Banach M, Bhatia V, Feller MA, Mujib M, Desai RV, Ahmed MI, Guichard JL, Aban I, Love TE, Aronow WS, White M, Deedwania P, Fonarow G, Ahmed A. Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure. Am J Cardiol. 2011 Apr 15; 107(8):1208-14. PMID: 21296319.


Fonseca V, Sharma PP, Shah M, Deedwania P. Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension. Curr Med Res Opin. 2011 Apr; 27(4):799-807. PMID: 21306286


Deedwania PC, Ahmed MI, Feller MA, Aban IB, Love TE, Pitt B, Ahmed A. Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure. Eur J Heart Fail. 2011 May; 13(5):551-9. PMID: 21393298.


Bharani A, Jain N, Jain A, Deedwania P. Endothelium-dependent vasodilation is impaired in healthy offspring of hypertensive parents. Indian Heart J. 2011 May-Jun; 63(3):255-8. PMID: 22734346


Mujib M, Desai RV, Ahmed MI, Guichard JL, Feller MA, Ekundayo OJ, Deedwania P, Ali M, Aban IB, Love TE, White M, Aronow WS, Rahimtoola SH, Bonow RO, Ahmed A. Rheumatic heart disease and risk of incident heart failure among community-dwelling older adults: a prospective cohort study. Ann Med. 2012 May; 44(3):253-61. PMID: 21254894.


Deedwania PC. Blood pressure control in diabetes mellitus: is lower always better, and how low should it go? Circulation. 2011 Jun 21; 123(24):2776-8. PMID: 21690500


Meyer P, Desai RV, Mujib M, Feller MA, Adamopoulos C, Banach M, Lainscak M, Aban I, White M, Aronow WS, Deedwania P, Iskandrian AE, Ahmed A. Right ventricular ejection fraction <20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients. Int J Cardiol. 2012 Feb 23; 155(1):120-5. PMID: 21664707.


Deedwania PC, Huang GW. Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation. Am J Cardiovasc Drugs. 2011 Aug 1; 11(4):265-75. PMID: 21740079


Guey LT, Pullinger CR, Ishida BY, O'Connor PM, Zellner C, Francone OL, Laramie JM, Naya-Vigne JM, Siradze KA, Deedwania P, Redberg RF, Frost PH, Seymour AB, Kane JP, Malloy MJ. Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease. Am J Cardiol. 2011 Aug 1; 108(3):360-6. PMID: 21757044


Deedwania PC, Carbajal EV. Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina. Am J Med. 2011 Aug; 124(8):681-8. PMID: 21787900
Deedwania P. ACP Journal Club. Review: rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes. Ann Intern Med. 2011 Aug 16; 155(4):JC2-12. PMID: 21844545


Roy B, Pawar PP, Desai RV, Fonarow GC, Mujib M, Zhang Y, Feller MA, Ovalle F, Aban IB, Love TE, Iskandrian AE, Deedwania P, Ahmed A. A propensity-matched study of the association of diabetes mellitus with incident heart failure and mortality among community-dwelling older adults. Am J Cardiol. 2011 Dec 15; 108(12):1747-53. PMID: 21943936.


Gupta R, Guptha S, Gupta VP, Agrawal A, Gaur K, Deedwania PC. Twenty-year trends in cardiovascular risk factors in India and influence of educational status. Eur J Prev Cardiol. 2012 Dec; 19(6):1258-71. PMID: 21947630


Arsenault BJ, Boekholdt SM, Hovingh GK, Hyde CL, DeMicco DA, Chatterjee A, Barter P, Deedwania P, Waters DD, LaRosa JC, Pedersen TR, Kastelein JJ. The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies. Circ Cardiovasc Genet. 2012 Feb 1; 5(1):51-7. PMID: 22135385


Luke MM, Berger K, Rowland CM, Catanese JJ, Tong CH, Ross DA, Garcia V, Kuhlenbaeumer G, Ringelstein EB, Pullinger CR, Malloy MJ, Deedwania P, Ellis SG, Kane JP, Devlin JJ, Lalouschek W, Mannhalter C. Polymorphisms and noncardioembolic stroke in three case-control studies. Cerebrovasc Dis. 2012; 33(1):80-5. PMID: 22134093


Deedwania P, Huang GW. An update on antithrombotic therapy in atrial fibrillation: the role of newer and emergent drugs. Rev Cardiovasc Med. 2012; 13(2-3):e89-104. PMID: 23160166


Qian F, Ling FS, Deedwania P, Hernandez AF, Fonarow GC, Cannon CP, Peterson ED, Peacock WF, Kaltenbach LA, Laskey WK, Schwamm LH, Bhatt DL. Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease program. Circ Cardiovasc Qual Outcomes. 2012 Jan; 5(1):126-33. PMID: 22235068


Ho JE, Waters DD, Kean A, Wilson DJ, Demicco DA, Breazna A, Wun CC, Deedwania PC, Khush KK. Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study). Am J Cardiol. 2012 Jun 15; 109(12):1761-6. PMID: 22459310.


Mora S, Wenger NK, Demicco DA, Breazna A, Boekholdt SM, Arsenault BJ, Deedwania P, Kastelein JJ, Waters DD. Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study. Circulation. 2012 Apr 24; 125(16):1979-87. PMID: 22461416.


Deedwania PC, Zappe DH, Egan BM, Purkayastha D, Samuel R, Sowers JR. Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide? J Clin Hypertens (Greenwich). 2012 Jul; 14(7):415-21. PMID: 22747613


Gupta R, Guptha S, Sharma KK, Gupta A, Deedwania P. Regional variations in cardiovascular risk factors in India: India heart watch. World J Cardiol. 2012 Apr 26; 4(4):112-20. PMID: 22558490.


Deedwania P, Huang GW. An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillation. Core Evid. 2012; 7:49-59. PMID: 22826692.


Lardizabal JA, Deedwania PC. Atrial fibrillation in heart failure. Med Clin North Am. 2012 Sep; 96(5):987-1000. PMID: 22980060


Gupta R, Deedwania PC, Sharma K, Gupta A, Guptha S, Achari V, Asirvatham AJ, Bhansali A, Gupta B, Gupta S, Jali MV, Mahanta TG, Maheshwari A, Saboo B, Singh J, Gupta R. Association of educational, occupational and socioeconomic status with cardiovascular risk factors in Asian Indians: a cross-sectional study. PLoS One. 2012; 7(8):e44098. PMID: 22952886.


Deedwania PC, Carbajal E. Evidence-based therapy for heart failure. Med Clin North Am. 2012 Sep; 96(5):915-31. PMID: 22980055


Deedwania PC. Heart failure: a common and complex clinical syndrome. Med Clin North Am. 2012 Sep; 96(5):xi-xii. PMID: 22980062


Rathi S, Deedwania PC. The epidemiology and pathophysiology of heart failure. Med Clin North Am. 2012 Sep; 96(5):881-90. PMID: 22980052


Bangalore S, Steg G, Deedwania P, Crowley K, Eagle KA, Goto S, Ohman EM, Cannon CP, Smith SC, Zeymer U, Hoffman EB, Messerli FH, Bhatt DL. ß-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012 Oct 3; 308(13):1340-9. PMID: 23032550


Deedwania P, Ahmed A. Prediabetes and the risk of diabetes. Lancet. 2012 Oct 6; 380(9849):1225; author reply 1226. PMID: 23040849


Deedwania PC. Ivabradine in heart failure: hope or hype? Am J Cardiovasc Drugs. 2012 Dec 1; 12(6):357-9. PMID: 23181943


Desai RV, Guichard JL, Mujib M, Ahmed MI, Feller MA, Fonarow GC, Meyer P, Iskandrian AE, Bogaard HJ, White M, Aban IB, Aronow WS, Deedwania P, Waagstein F, Ahmed A. Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving ß-blockers: insights from the BEST trial. Int J Cardiol. 2013 Feb 10; 163(1):61-7. PMID: 21704392.


Gupta R, Deedwania PC, Achari V, Bhansali A, Gupta BK, Gupta A, Mahanta TG, Asirvatham AJ, Gupta S, Maheshwari A, Saboo B, Jali MV, Singh J, Guptha S, Sharma KK. Normotension, prehypertension, and hypertension in urban middle-class subjects in India: prevalence, awareness, treatment, and control. Am J Hypertens. 2013 Jan; 26(1):83-94. PMID: 23382331


Deedwania PC. New oral anticoagulants in elderly patients with atrial fibrillation. Am J Med. 2013 Apr; 126(4):289-96. PMID: 23369212


Deedwania P, Shea J, Chen W, Brener L. Effects of add-on nebivolol on blood pressure and glucose parameters in hypertensive patients with prediabetes. J Clin Hypertens (Greenwich). 2013 Apr; 15(4):270-8. PMID: 23551727


Deedwania P. Diabetes, cardiovascular disease, and ethnicity. J Am Coll Cardiol. 2013 Apr 30; 61(17):1787-9. PMID: 23500320


Bethel MA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Kahn SE, Levitt NS, McMurray JJ, Califf RM, Raptis SA, Thomas L, Sun JL, Haffner SM. A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk. Am J Cardiol. 2013 Jul 15; 112(2):231-7. PMID: 23608615


Deedwania P, Patel K, Fonarow GC, Desai RV, Zhang Y, Feller MA, Ovalle F, Love TE, Aban IB, Mujib M, Ahmed MI, Anker SD, Ahmed A. Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study. Int J Cardiol. 2013 Oct 9; 168(4):3616-22. PMID: 23731526.


Deedwania PC, Gupta R, Sharma KK, Achari V, Gupta B, Maheshwari A, Gupta A. High prevalence of metabolic syndrome among urban subjects in India: a multisite study. Diabetes Metab Syndr. 2014 Jul-Sep; 8(3):156-61. PMID: 25220918


Bangalore S, Fayyad R, Laskey R, DeMicco D, Deedwania P, Kostis JB, Messerli FH. Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trial. Eur Heart J. 2014 Jul 14; 35(27):1801-8. PMID: 23990605


Heart Failure (MERIT-HF). Circulation. 2002 Mar 12;105(10):1182-8. PubMed PMID: 11889011.


Spertus JA, Tooley J, Jones P, Poston C, Mahoney E, Deedwania P, Hurley S, Pitt B, Weintraub WS. Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study). Am Heart J. 2002 Apr;143(4):636-42. PubMed PMID: 11923800.


Ghali JK, Piña IL, Gottlieb SS, Deedwania PC, Wikstrand JC; MERIT-HF Study Group. Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation. 2002 Apr 2;105(13):1585-91. PubMed PMID: 11927527.


Kerensky RA, Wade M, Deedwania P, Boden WE, Pepine CJ; Veterans Affairs Non-Q-Wave Infarction Stategies in-Hospital (VANQWISH) Trial Investigators. Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory. J Am Coll Cardiol. 2002 May 1;39(9):1456-63. PubMed PMID: 11985907.


Reynolds HQ, Deedwania PC. Treating hypertension in patients with diabetes. Nurse Pract. 2002 Jul;27(7):11-21; quiz 21-3. Review. Erratum in: Nurse Pract 2002 Oct;27(10):11. PubMed PMID: 12131797.


Khand AU, Cleland JG, Deedwania PC. Prevention of and medical therapy for atrial arrhythmias in heart failure. Heart Fail Rev. 2002 Jul;7(3):267-83. Review. PubMed PMID: 12215732.

 

Matalka MS, Ravnan MC, Deedwania PC. Is alternate daily dose of atorvastatin effective in treating patients with hyperlipidemia? The Alternate Day Versus Daily Dosing of Atorvastatin Study (ADDAS). Am Heart J. 2002 Oct;144(4):674-7. PubMed PMID: 12360164.


Deedwania PC. Heart failure in the elderly: is beta-blockade the standard of care? Postgrad Med. 2002 Dec;112(6 Suppl Heart):21-7. doi: 10.3810/pgm.12.2002.suppl24.127. PubMed PMID: 19667614.


Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV; American College of Cardiology; American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol. 2003 Jan 1;41(1):159-68. PubMed PMID: 12570960.


Deedwania PC. Diabetes and vascular disease: common links in the emerging epidemic of coronary artery disease. Am J Cardiol. 2003 Jan 1;91(1):68-71. Review. PubMed PMID: 12505574.


Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Gibbons RJ, Alpert JS, Antman EM, Hiratzka LF, Fuster V, Faxon DP, Gregoratos G, Jacobs AK, Smith SC Jr; American College of Cardiology; American Heart Association Task Force on Practice Guidelines. Committee on the Management of Patients With Chronic Stable Angina. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation. 2003 Jan 7;107(1):149-58. PubMed PMID: 12515758.


Deedwania PC. The key to unraveling the mystery of mortality in heart failure: an integrated approach. Circulation. 2003 Apr 8;107(13):1719-21. PubMed PMID: 12682028.


Ravnan SL, Deedwania PC. The rational use of diuretics in heart failure. Curr Cardiol Rep. 2003 May;5(3):237-42. Review. PubMed PMID: 12691643.


Gupta R, Sharma AK, Gupta VP, Bhatnagar S, Rastogi S, Deedwania PC. Increased variance in blood pressure distribution and changing hypertension prevalence in an urban Indian population. J Hum Hypertens. 2003 Aug;17(8):535-40. PubMed PMID: 12874610.


Deedwania PC. Mechanisms of endothelial dysfunction in the metabolic syndrome. Curr Diab Rep. 2003 Aug;3(4):289-92. Review. PubMed PMID: 12866990.


Goldstein S, Deedwania P, Gottlieb S, Wikstrand J; MERIT-HF Study Group. Metoprolol CR/XL in black patients with heart failure (from the Metoprolol CR/XL randomized intervention trial in chronic heart failure). Am J Cardiol. 2003 Aug15;92(4):478-80. PubMed PMID: 12914886.


Wikstrand J, Wedel H, Ghali J, Deedwania P, Fagerberg B, Goldstein S, Gottlieb S, Hjalmarson A, Kjekshus J, Waagstein F. How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Card Electrophysiol Rev. 2003 Sep;7(3):264-75. PubMed PMID: 14739726.


Domanski M, Krause-Steinrauf H, Deedwania P, Follmann D, Ghali JK, Gilbert E, Haffner S, Katz R, Lindenfeld J, Lowes BD, Martin W, McGrew F, Bristow MR; BEST Investigators. The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. J Am Coll Cardiol. 2003 Sep 3;42(5):914-22. PubMed PMID: 12957443.


Domanski MJ, Krause-Steinrauf H, Massie BM, Deedwania P, Follmann D, Kovar D, Murray D, Oren R, Rosenberg Y, Young J, Zile M, Eichhorn E; BEST Investigators. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS. J Card Fail. 2003 Oct;9(5):354-63. Review. PubMed PMID: 14583895.


Deedwania PC. Metabolic syndrome and vascular disease: is nature or nurture leading the new epidemic of cardiovascular disease? Circulation. 2004 Jan 6;109(1):2-4. Review. PubMed PMID: 14707015.


Deedwania PC, Hunninghake DB, Bays H. Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndrome. Am J Cardiol. 2004 Jun 3;93(11A):18C-26C. Review. PubMed PMID: 15178513.


Deedwania PC, Gottlieb S, Ghali JK, Waagstein F, Wikstrand JC; MERIT-HF Study Group. Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure. Eur Heart J. 2004 Aug;25(15):1300-9. Erratum in: Eur Heart J. 2004 Nov;25(21):1968. PubMed PMID: 15288157.


Deedwania PC, Davidson MH, Ballantyne CM. Treating dyslipidemia in high-risk patients: case reviews and discussion. Postgrad Med. 2004 Sep;116(3 Suppl):21-8. doi: 10.3810/pgm.09.2004.suppl34.210. PubMed PMID: 19667672.


Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K. Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol 2004 Nov;97(2):257-61. PubMed PMID: 15458693.


Mensah GA, Mokdad AH, Ford E, Narayan KM, Giles WH, Vinicor F, Deedwania PC. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications. Cardiol Clin. 2004 Nov;22(4):485-504. Review. PubMed PMID: 15501618.


Deedwania PC. Diabetes is a vascular disease: the role of endothelial dysfunction in pathophysiology of cardiovascular disease in diabetes. Cardiol Clin. 2004 Nov;22(4):505-9, v. Review. PubMed PMID: 15501619.


Ghali JK, Dunselman P, Waagstein F, Goldstein S, Gottlieb SS, Deedwania PC, Wikstrand JC. Consistency of the beneficial effect of metoprolol succinate extended release across a wide range dose of angiotensin-converting enzyme ninhibitors and digitalis. J Card Fail. 2004 Dec;10(6):452-9. PubMed PMID:15599834.


Deedwania PC; Study Assessing Goals in the Elderly steering committee and investigators. Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: the rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE). Am Heart J. 2004 Dec;148(6):1053-9. PubMed PMID: 15632893.


Deedwania PC, Giles TD, Klibaner M, Ghali JK, Herlitz J, Hildebrandt P, Kjekshus J, Spinar J, Vitovec J, Stanbrook H, Wikstrand J; MERIT-HF Study Group. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF. Am Heart J. 2005 Jan;149(1):159-67. PubMed PMID: 15660048.


Gullestad L, Wikstrand J, Deedwania P, Hjalmarson A, Egstrup K, Elkayam U, Gottlieb S, Rashkow A, Wedel H, Bermann G, Kjekshus J; MERIT-HF Study Group. Whatresting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF). J Am Coll Cardiol. 2005 Jan 18;45(2):252-9. PubMed PMID: 15653024.


Deedwania PC, Hunninghake DB, Bays HE, Jones PH, Cain VA, Blasetto JW; STELLAR Study Group. Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome. Am J Cardiol. 2005 Feb 1;95(3):360-6. PubMed PMID: 15670545.


Deedwania P, Volkova N. Dyslipidemia and lipid-lowering therapy in the elderly. Expert Rev Cardiovasc Ther. 2005 May;3(3):453-63. Review. PubMed PMID: 15889973.


Deedwania PC, Volkova N. Current Treatment Options for the Metabolic Syndrome. Curr Treat Options Cardiovasc Med. 2005 May;7(1):61-74. PubMed PMID:15913505.


Deedwania PC. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy. Cardiol Clin. 2005 May;23(2):139-52. Review. PubMed PMID: 15694743.


Vijayaraghavan K, Deedwania PC. The renin angiotensin system as a therapeutic target to prevent diabetes and its complications. Cardiol Clin. 2005 May;23(2):165-83. Review. PubMed PMID: 15694745.


Srikanth S, Deedwania P. Comprehensive risk reduction of cardiovascular risk factors in the diabetic patient: an integrated approach. Cardiol Clin. 2005 May;23(2):193-210. Review. PubMed PMID: 15694747.


Misra UK, Deedwania R, Pizzo SV. Binding of activated alpha2-macroglobulin to its cell surface receptor GRP78 in 1-LN prostate cancer cells regulates PAK-2-dependent activation of LIMK. J Biol Chem. 2005 Jul 15;280(28):26278-86. Epub 2005 May 20. PubMed PMID: 15908432; PubMed Central PMCID: PMC1201553.


Davidson MH, Maki KC, Pearson TA, Pasternak RC, Deedwania PC, McKenney JM, Fonarow GC, Maron DJ, Ansell BJ, Clark LT, Ballantyne CM. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Am J Cardiol. 2005 Aug 15;96(4):556-63. PubMed PMID: 16098311.


Deedwania P. Avoid the rush to judgment in acute coronary syndromes. Postgrad Med. 2005 Sep;118(3):11-4, 22. PubMed PMID: 16201303.


Amsterdam EA, Deedwania P. Bedside evaluation of cardiac markers. Point-of-care testing can differentiate acute coronary syndromes. Postgrad Med. 2005 Sep;118(3):15-6, 19-22. Review. PubMed PMID: 16201304.


Carbajal EV, Deedwania P. Treating non-ST-segment elevation ACS. Pros and cons of current strategies. Postgrad Med. 2005 Sep;118(3):23-32. Review. PubMed PMID: 16201305.


Deedwania P. Intensive lipid-lowering is no more effective than diet and low-dose lovastatin for reducing ischaemia in people with heart disease. Commentary. Evid Based Cardiovasc Med. 2005 Sep;9(3):241-4. Epub 2005 Jul 26. PubMed PMID: 16380043.


Deedwania PC, Fonseca VA. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm. Am J Med. 2005 Sep;118(9):939-47. Review. PubMed PMID:16164876.


Deedwania P, Singh V. Coronary artery disease in South Asians: evolving strategies for treatment and prevention. Indian Heart J. 2005 Nov-Dec;57(6):617-31. Review. PubMed PMID: 16521627.


Caro JJ, Migliaccio-Walle K, O'Brien JA, Nova W, Kim J, Hauch O, Hillson E, Wedel H, Hjalmarson A, Gottlieb S, Deedwania PC, Wikstrand J; MERIT-HF Study Group. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial. J Card Fail. 2005 Dec;11(9):647-56. PubMed PMID: 16360958.


Singh V, Deedwania P. Dyslipidemia in special populations: Asian Indians, African Americans, and Hispanics. Curr Atheroscler Rep. 2006 Jan;8(1):32-40. Review. PubMed PMID: 16455012.


Misra UK, Deedwania R, Pizzo SV. Activation and cross-talk between Akt, NF-kappaB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78. J Biol Chem. 2006 May 12;281(19):13694-707. Epub 2006 Mar 16. PubMed PMID: 16543232.


Pitt B, Fonarow GC, Gheorghiade M, Deedwania PC, Duprez DA. Improving outcomes in post-acute myocardial infarction heart failure: incorporation of aldosterone blockade into combination therapy to optimize neurohormonal blockade. Am J Cardiol. 2006 May 22;97(10A):26F-33F. Epub 2006 Apr 17. Review. PubMed PMID: 16698332.


Deedwania PC, Schmieder R. Angiotensin receptor blockers: Cardiovascular protection in the metabolic syndrome. J Renin Angiotensin Aldosterone Syst. 2006 Jun;7 Suppl 1:S12-8. Review. PubMed PMID: 16986230.


Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart JC, Haffner S, Hsia J, Breazna A, LaRosa J, Grundy S, Waters D. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study. Diabetes Care. 2006 Jun;29(6):1220-6. PubMed PMID: 16731999.


Deedwania P, Barter P, Carmena R, Fruchart JC, Grundy SM, Haffner S, Kastelein JJ, LaRosa JC, Schachner H, Shepherd J, Waters DD; Treating to New Targets Investigators. Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. Lancet. 2006 Sep 9;368(9539):919-28. PubMed PMID: 16962881.


Deedwania PC, Maki KC, Dicklin MR, Stone NJ, Ballantyne CM, Davidson MH. Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II). J Cardiometab Syndr. 2006 Fall;1(5):295-300. PubMed PMID: 17679790.


Deedwania PC, Gupta R. Management issues in the metabolic syndrome. J Assoc Physicians India. 2006 Oct;54:797-810. Review. PubMed PMID: 17214277.


Deedwania PC, Smith DG. Clinical efficacy and cost-effectiveness of rosuvastatin. Expert Rev Pharmacoecon Outcomes Res. 2007 Feb;7(1):31-9. doi: 10.1586/14737167.7.1.31. PubMed PMID: 20528428.


Deedwania PC, Carbajal EV, Bobba VR. Trials and tribulations associated with angina and traditional therapeutic approaches. Clin Cardiol. 2007 Feb;30(2 Suppl 1):I16-24. Review. PubMed PMID: 18373326.


Khush KK, Waters DD, Bittner V, Deedwania PC, Kastelein JJ, Lewis SJ, Wenger NK. Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study. Circulation. 2007 Feb 6;115(5):576-83. Epub 2007 Jan 29. PubMed PMID: 17261662.


Deedwania P, Stone PH, Bairey Merz CN, Cosin-Aguilar J, Koylan N, Luo D, Ouyang P, Piotrowicz R, Schenck-Gustafsson K, Sellier P, Stein JH, Thompson PL, Tzivoni D. Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE). Circulation. 2007 Feb 13;115(6):700-7. Epub 2007 Feb 5. PubMed PMID: 17283260.


Stein PK, Tereshchenko L, Domitrovich PP, Kleiger RE, Perez A, Deedwania P. Diastolic dysfunction and autonomic abnormalities in patients with systolic heart failure. Eur J Heart Fail. 2007 Apr;9(4):364-9. Epub 2006 Nov 22. PubMed PMID:17123863.


Kosiborod M, Soto GE, Jones PG, Krumholz HM, Weintraub WS, Deedwania P, Spertus JA. Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments. Circulation. 2007 Apr 17;115(15):1975-81. Epub 2007 Apr 9. PubMed PMID: 17420346.


Deedwania PC, Gupta M, Stein M, Ycas J, Gold A; IRIS Study Group. Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial). Am J Cardiol. 2007 Jun 1;99(11):1538-43. Epub 2007 Apr 16. PubMed PMID: 17531577.


Srikanth S, Deedwania P. Management of coronary artery disease in patients with type 2 diabetes mellitus. Curr Cardiol Rep. 2007 Jul;9(4):264-71. Review. PubMed PMID: 17601392.


Ford GA, Choy AM, Deedwania P, Karalis DG, Lindholm CJ, Pluta W, Frison L, Olsson SB; SPORTIF III, V Investigators. Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V Trials. Stroke. 2007 Nov;38(11):2965-71. Epub 2007 Sep 20. PubMed PMID: 17885258.


Deedwania P. Evolving treatment options for prevention of cardiovascular events in high-risk hypertensive patients. J Clin Hypertens (Greenwich). 2007 Nov;9(11):883-8. Review. PubMed PMID: 17978596.


Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK; Treating to New Targets Investigators. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol. 2007 Nov;2(6):1131-9. Epub 2007 Oct 17. PubMed PMID: 17942759.


Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK; Treating to New Targets Investigators. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol. 2007 Nov;2(6):1131-9. Epub 2007 Oct 17. PubMed PMID: 17942759.


Fraker TD Jr, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM, O'Rourke RA, Williams SV, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW; American College of Cardiology; American Heart Association; American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group. 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina. Circulation. 2007 Dec 4;116(23):2762-72. Epub 2007 Nov 12. Erratum in: Circulation. 2007 Dec 4;116(23):e558. Pasternak, Richard C [removed]. PubMed PMID: 17998462.


Gupta R, Gupta VP, Bhagat N, Rastogi P, Sarna M, Prakash H, Deedwania PC. Obesity is major determinant of coronary risk factors in India: Jaipur Heart Watch studies. Indian Heart J. 2008 Jan-Feb;60(1):26-33. PubMed PMID: 19212018.


Deedwania P, Srikanth S. Diabetes and vascular disease. Expert Rev Cardiovasc Ther. 2008 Jan;6(1):127-38. Review. PubMed PMID: 18095912.


Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P; American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2008 Mar 25;117(12):1610-9. doi: 10.1161/CIRCULATIONAHA.107.188629. Epub 2008 Feb 25. Erratum in: Circulation. 2010 Jun 15;121(23):e444. PubMed PMID: 18299505.


Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK; TNT (Treating to New Targets) Investigators. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study. J Am Coll Cardiol. 2008 Apr 15;51(15):1448-54. doi: 10.1016/j.jacc.2007.11.072. PubMed PMID: 18402899.


Kostis JB, Breazna A, Deedwania PC, LaRosa JC; Treating to New Targets Steering Committee and Investigators. The benefits of intensive lipid lowering in patients with stable coronary heart disease with normal or high systolic blood pressure: an analysis of the Treating to New Targets (TNT) study. J Clin Hypertens (Greenwich). 2008 May;10(5):367-76. PubMed PMID: 18453796.


Singh V, Deedwania P. Expanding roles for atorvastatin. Drugs Today (Barc). 2008 Jun;44(6):455-71. doi: 10.1358/dot.2008.44.6.1217468. Review. PubMed PMID:18596999.


Kastelein JJ, van der Steeg WA, Holme I, Gaffney M, Cater NB, Barter P, Deedwania P, Olsson AG, Boekholdt SM, Demicco DA, Szarek M, LaRosa JC, Pedersen TR, Grundy SM; TNT Study Group; IDEAL Study Group. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation. 2008 Jun 10;117(23):3002-9. doi: 10.1161/CIRCULATIONAHA.107.713438. Epub 2008 Jun 2. PubMed PMID: 18519851.


Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Anesthesiology. 2008 Jul;109(1):14-24. doi: 10.1097/ALN.0b013e31817dced3. PubMed PMID: 18580168.


Shepherd J, Kastelein JP, Bittner VA, Carmena R, Deedwania PC, Breazna A, Dobson S, Wilson DJ, Zuckerman AL, Wenger NK; Treating to New Targets Steering Committee and Investigators. Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease. Mayo Clin Proc. 2008 Aug;83(8):870-9. PubMed PMID: 18674471.


Stein PK, Sanghavi D, Domitrovich PP, Mackey RA, Deedwania P. Ambulatory ECG-based T-wave alternans predicts sudden cardiac death in high-risk post-MI patients with left ventricular dysfunction in the EPHESUS study. J Cardiovasc Electrophysiol. 2008 Oct;19(10):1037-42. doi: 10.1111/j.1540-8167.2008.01225.x. Epub 2008 Jun 28. PubMed PMID: 18554193.


Javed U, Deedwania PC. Angiotensin receptor blockers: novel role in high-risk patients. Cardiol Clin. 2008 Nov;26(4):507-26. doi: 10.1016/j.ccl.2008.07.001. Review. PubMed PMID: 18929228.
Deedwania PC, Javed U. Statins in heart failure. Cardiol Clin. 2008Nov;26(4):573-87. doi: 10.1016/j.ccl.2008.06.006. Review. PubMed PMID: 18929232.


Ram CV, Deedwania PC. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET? Am J Cardiol. 2008 Nov 1;102(9):1281-3. doi: 10.1016/j.amjcard.2008.06.043. Epub 2008 Aug 15. PubMed PMID: 18940307.


Zappe DH, Sowers JR, Hsueh WA, Haffner SM, Deedwania PC, Fonseca VA, Keeling L, Sica DA. Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome. J Clin Hypertens (Greenwich). 2008 Dec;10(12):894-903. doi: 10.1111/j.1751-7176.2008.00054.x. PubMed PMID: 19120715.


Singh V, Deedwania P. Reducing morbidity and mortality in high risk patients with statins. Vasc Health Risk Manag. 2009;5(2):495-507. Epub 2009 Jun 7. Review. PubMed PMID: 19554090; PubMed Central PMCID: PMC2697584.


Sharma KK, Gupta R, Agrawal A, Roy S, Kasliwal A, Bana A, Tongia RK, Deedwania PC. Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India. Vasc Health Risk Manag. 2009;5:1007-14. Epub 2009 Nov 23. PubMed PMID: 19997570; PubMed Central PMCID:PMC2788593.


Deedwania PC, Carbajal EV. Getting with the ACC/AHA guidelines for the treatment of chronic angina as a disease state. Rev Cardiovasc Med. 2009;10 Suppl1:S11-20. Review. PubMed PMID: 19898283.


Deedwania P. Contemporary approaches for cardiovascular risk reduction in diabetes. Indian Heart J. 2009 Jan-Feb;61(1):24-33. Review. PubMed PMID:19729685.


Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009 Jan;32(1):187-92. doi: 10.2337/dc08-9026. Epub 2008 Dec 17. Erratum in: Diabetes Care. 2009 Apr;32(4):754. PubMed PMID: 19092168; PubMed Central PMCID: PMC2606812.


Sachdeva A, Cannon CP, Deedwania PC, Labresh KA, Smith SC Jr, Dai D, Hernandez A, Fonarow GC. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J. 2009 Jan;157(1):111-117.e2. doi: 10.1016/j.ahj.2008.08.010. Epub 2008 Oct 22. PubMed PMID: 19081406.


Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol. 2009 Jan 20;53(3):298-304. doi: 10.1016/j.jacc.2008.10.008. Review. PubMed PMID: 19147051.


Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation. 2009 Jan 20;119(2):351-7. doi: 10.1161/CIRCULATIONAHA.108.191305. Epub 2008 Dec 17. Erratum in: Circulation. 2009 Jun 30;119(25):e605. PubMed PMID: 19095622.


Deedwania P. The endocannabinoid system and cardiometabolic risk: effects of CB1 receptor blockade on lipid metabolism. Int J Cardiol. 2009 Jan 24;131(3):305-12. doi: 10.1016/j.ijcard.2008.06.033. Epub 2008 Aug 19. Review. PubMed PMID: 18715660.


Fonarow GC, Deedwania P, Fonseca V, Nesto RW, Watson K, Tarka E, Lukas MA, Madan A, Shabbout M. Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial. J Am Soc Hypertens. 2009 May-Jun;3(3):210-20. doi: 10.1016/j.jash.2009.01.004. Epub 2009 Mar 29. PubMed PMID: 20409961.


Stein PK, Deedwania P. Usefulness of abnormal heart rate turbulence to predict cardiovascular mortality in high-risk patients with acute myocardial infarction and left ventricular dysfunction (from the EPHESUS study). Am J Cardiol. 2009 Jun 1;103(11):1495-9. doi: 10.1016/j.amjcard.2009.01.362. Epub 2009 Apr 8. PubMed PMID: 19463505.


Kosiborod M, Deedwania P. An overview of glycemic control in the coronary care unit with recommendations for clinical management. J Diabetes Sci Technol. 2009 Nov 1;3(6):1342-51. Review. PubMed PMID: 20144388; PubMed Central PMCID:PMC2787034.


Javed U, Deedwania PC. Beta-adrenergic blockers for chronic heart failure. Cardiol Rev. 2009 Nov-Dec;17(6):287-92. doi: 10.1097/CRD.0b013e3181bdf63e. Review. PubMed PMID: 19829179

.
Deedwania P, Singh V, Davidson MH. Low high-density lipoprotein cholesterol and increased cardiovascular disease risk: an analysis of statin clinical trials. Am J Cardiol. 2009 Nov 16;104(10 Suppl):3E-9E. doi:10.1016/j.amjcard.2009.09.013. PubMed PMID: 19895938. Bethel MA,

 

Deedwania P, Levitt NS, Schmitz O, Huntsman-Labed A, Califf RM,Haffner SM, Diem P; NAVIGATOR Study Group. Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population. Diabet Med. 2009 Dec;26(12):1204-11. doi: 10.1111/j.1464-5491.2009.02864.x. PubMed PMID: 20002471.


LaRosa JC, Deedwania PC, Shepherd J, Wenger NK, Greten H, DeMicco DA, Breazna A; TNT Investigators. Comparison of 80 versus 10 mg of atorvastatin on occurrence of cardiovascular events after the first event (from the Treating to New Targets [TNT] trial). Am J Cardiol. 2010 Feb 1;105(3):283-7. doi: 10.1016/j.amjcard.2009.09.025. Epub 2009 Dec 22. PubMed PMID: 20102935.


Lardizabal JA, Deedwania PC. The current state of beta blockers in hypertension therapy. Indian Heart J. 2010 Mar-Apr;62(2):111-7. Review. PubMed PMID: 21180299.


Deedwania PC, Lardizabal JA. Atrial fibrillation in heart failure: a comprehensive review. Am J Med. 2010 Mar;123(3):198-204. doi: 10.1016/j.amjmed.2009.06.033. Review. PubMed PMID: 20193823.


Ho JE, Bittner V, Demicco DA, Breazna A, Deedwania PC, Waters DD. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial). Am J Cardiol. 2010 Apr 1;105(7):905-11. doi: 10.1016/j.amjcard.2009.11.035. PubMed PMID: 20346304.


NAVIGATOR Study Group, Holman RR, Haffner SM, McMurray JJ, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E, Ilkova H, Jenssen T, Kahn SE, Krum H, Laakso M, Leiter LA, Levitt NS, Mareev V, Martinez F, Masson C, Mazzone T, Meaney E, Nesto R, Pan C, Prager R, Raptis SA, Rutten GE, Sandstroem H, Schaper F, Scheen A, Schmitz O, Sinay I, Soska V, Stender S, Tamás G, Tognoni G, Tuomilehto J, Villamil AS, Vozár J, Califf RM. Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010 Apr 22;362(16):1463-76. doi: 10.1056/NEJMoa1001122. Epub 2010 Mar 14. Erratum in: N Engl J Med. 2010 May 6;362(18):1748. PubMed PMID: 20228402.


NAVIGATOR Study Group, McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E, Ilkova H, Jenssen T, Kahn SE, Krum H, Laakso M, Leiter LA, Levitt NS, Mareev V, Martinez F, Masson C, Mazzone T, Meaney E, Nesto R, Pan C, Prager R, Raptis SA, Rutten GE, Sandstroem H, Schaper F, Scheen A, Schmitz O, Sinay I, Soska V, Stender S, Tamás G, Tognoni G, Tuomilehto J, Villamil AS, Vozár J, Califf RM. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010 Apr 22;362(16):1477-90. doi: 0.1056/NEJMoa1001121. Epub 2010 Mar 14. Erratum in: N Engl J Med. 2010 May 6;362(18):1748. PubMed PMID: 20228403.


Desai RV, Banach M, Ahmed MI, Mujib M, Aban I, Love TE, White M, Fonarow G, Deedwania P, Aronow WS, Ahmed A. Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial). Am J Cardiol. 2010 Jul 15;106(2):221-7 doi:10.1016/j.amjcard.2010.02.032. PubMed PMID: 20599007; PubMed Central PMCID:PMC2945308.


Sowers JR, Raij L, Jialal I, Egan BM, Ofili EO, Samuel R, Zappe DH, Purkayastha D, Deedwania PC. Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives. J Hypertens. 2010 Aug;28(8):1761-9. doi: 10.1097/HJH.0b013e32833af380. PubMed PMID: 20498618; PubMed Central PMCID: PMC2908201.


Stein PK, Deedwania P. New York Heart Association functional class influences the impact of diabetes on cardiac autonomic function. J Electrocardiol. 2010 Sep Oct;43(5):379-84. doi: 10.1016/j.jelectrocard.2009.12.008. Epub 2010 Jan 25. PubMed PMID: 20096854.


Srikanth S, Deedwania P. Hypertension as a cardiometabolic risk. Indian Heart J. 2010 Sep-Oct;62(5):394-401. Review. PubMed PMID: 23189879.


Deedwania PC. Risk of diabetes and cardiovascular disease: best to return back to the basics: comment on "Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus". Arch Intern Med. 2010 Sep 27;170(17):1575-7. doi: 10.1001/archinternmed.2010.333. PubMed PMID: 20876409.


Lardizabal JA, Deedwania PC. Benefits of statin therapy and compliance in high risk cardiovascular patients. Vasc Health Risk Manag. 2010 Oct 5;6:843-53. doi: 10.2147/VHRM.S9474. Review. PubMed PMID: 20957130; PubMed Central PMCID:PMC2952453

.
Singh V, Sharma R, Kumar A, Deedwania P. Low high-density lipoprotein cholesterol: current status and future strategies for management. Vasc Health Risk Manag. 2010 Oct 29;6:979-96. doi: 10.2147/VHRM.S5685. Review. PubMed PMID: 21127701; PubMed Central PMCID: PMC2988622.


Lardizabal JA, Deedwania PC. The role of renin-angiotensin agents in altering the natural history of type 2 diabetes mellitus. Curr Cardiol Rep. 2010 Nov;12(6):464-71. doi: 10.1007/s11886-010-0138-1. Review. PubMed PMID: 20809236; PubMed Central PMCID: PMC2939350.


Javed U, Deedwania PC, Bhatt DL, Cannon CP, Dai D, Hernandez AF, Peterson ED, Fonarow GC. Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG). Am Heart J. 2010 Dec;160(6):1130-6, 1136.e1-3. doi: 10.1016/j.ahj.2010.08.041. PubMed PMID: 21146668.


Deedwania P. Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating β-blockers. J Clin Hypertens (Greenwich). 2011 Jan;13(1):52-9. doi:10.1111/j.1751-7176.2010.00386.x. Epub 2010 Nov 8. Review. PubMed PMID: 21214722.


Arsenault BJ, Barter P, DeMicco DA, Bao W, Preston GM, LaRosa JC, Grundy SM, Deedwania P, Greten H, Wenger NK, Shepherd J, Waters DD, Kastelein JJ; TNT Study Investigators. Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers. J Am Coll Cardiol. 2011 Jan 4;57(1):63-9. doi: 10.1016/j.jacc.2010.06.052. Retraction in: J Am Coll Cardiol. 2013 Apr 23;61(16):1750. PubMed PMID: 21185503.


Adamopoulos C, Meyer P, Desai RV, Karatzidou K, Ovalle F, White M, Aban I, Love TE, Deedwania P, Anker SD, Ahmed A. Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study. Eur. J Heart Fail. 2011 Feb;13(2):200-6. doi: 10.1093/eurjhf/hfq159. Epub 2010 Oct 7. PubMed PMID: 20930001; PubMed Central PMCID: PMC3025667.


Lardizabal JA, Deedwania PC. The anti-ischemic and anti-anginal properties of statins. Curr Atheroscler Rep. 2011 Feb;13(1):43-50. doi:10.1007/s11883-010-0147-y. Review. PubMed PMID: 21107759; PubMed Central PMCID: PMC3018271.


Deedwania P. Preface cardiovascular disease prevention: the continuum of primary and secondary prevention. Cardiol Clin. 2011 Feb;29(1):xi-xiii. doi: 10.1016/j.ccl.2010.12.001. PubMed PMID: 21257096.


Gupta R, Deedwania P. Interventions for cardiovascular disease prevention. Cardiol Clin. 2011 Feb;29(1):15-34. doi: 10.1016/j.ccl.2010.10.005. Review. PubMed PMID: 21257098.


Srikanth S, Deedwania P. Primary and secondary prevention strategy for cardiovascular disease in diabetes mellitus. Cardiol Clin. 2011 Feb;29(1):47-70. doi: 10.1016/j.ccl.2010.11.004. Review. PubMed PMID: 21257100.


Lardizabal JA, Deedwania P. Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular disease. Cardiol Clin. 2011 Feb;29(1):87-103. doi: 10.1016/j.ccl.2010.10.002. Review. PubMed PMID: 21257102.


Vijayaraghavan K, Deedwania P. Renin-angiotensin-aldosterone blockade for cardiovascular disease prevention. Cardiol Clin. 2011 Feb;29(1):137-56. doi: 10.1016/j.ccl.2010.11.003. Review. PubMed PMID: 21257105.


Carbajal EV, Deedwania P. Role of medical versus interventional strategies to prevent coronary events in patients with stable coronary artery disease. Cardiol Clin. 2011 Feb;29(1):157-65. doi: 10.1016/j.ccl.2010.11.001. Review. PubMed PMID:21257106.


Javed U, Deedwania PC, Bhatt DL, Cannon CP, Dai D, Hernandez A, Peterson ED, Fonarow GC. Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospital participating in Get With The Guidelines (GWTG). Am Heart J. 2011 Feb;161(2):418-424.e1-3. PubMed PMID: 21404720.


Mujib M, Rahman AA, Desai RV, Ahmed MI, Feller MA, Aban I, Love TE, White M, Deedwania P, Aronow WS, Fonarow G, Ahmed A. Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves. Am J Cardiol. 2011 Feb 15;107(4):552-7. doi: 10.1016/j.amjcard.2010.10.012. Epub 2010 Dec 22. PubMed PMID: 21185004; PubMed Central PMCID: PMC3053576.


Fonseca V, Sharma PP, Shah M, Deedwania P. Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension. Curr Med Res Opin. 2011 Apr;27(4):799-807. doi: 10.1185/03007995.2011.555477. Epub 2011 Feb PubMed PMID: 21306286.


Banach M, Bhatia V, Feller MA, Mujib M, Desai RV, Ahmed MI, Guichard JL, Aban I, Love TE, Aronow WS, White M, Deedwania P, Fonarow G, Ahmed A. Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure. Am J Cardiol. 2011 Apr 15;107(8):1208-14. doi: 10.1016/j.amjcard.2010.12.020. Epub 2011 Feb 4. PubMed PMID: 21296319; PubMed Central PMCID: PMC3072746.


Bharani A, Jain N, Jain A, Deedwania P. Endothelium-dependent vasodilation is impaired in healthy offspring of hypertensive parents. Indian Heart J. 2011 May-Jun;63(3):255-8. PubMed PMID: 22734346.


Deedwania PC, Ahmed MI, Feller MA, Aban IB, Love TE, Pitt B, Ahmed A. Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure. Eur J Heart Fail. 2011 May;13(5):551-9. doi: 10.1093/eurjhf/hfr009. Epub 2011 Mar 9. PubMed PMID: 21393298; PubMed Central PMCID: PMC3079464.


Deedwania PC. Blood pressure control in diabetes mellitus: is lower always better, and how low should it go? Circulation. 2011 Jun 21; 123(24):2776-8. doi: 10.1161/CIRCULATIONAHA.111.033704. PubMed PMID: 21690500.


Deedwania PC, Carbajal EV. Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina. Am J Med. 2011 Aug;124(8):681-8. doi: 10.1016/j.amjmed.2011.02.036. Review. PubMed PMID: 21787900.


Deedwania PC, Huang GW. Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation. Am J Cardiovasc Drugs. 2011 Aug 1;11(4):265-75. doi: 10.2165/11592410-000000000-00000. Review. PubMed PMID: 21740079.


Guey LT, Pullinger CR, Ishida BY, O'Connor PM, Zellner C, Francone OL, Laramie JM, Naya-Vigne JM, Siradze KA, Deedwania P, Redberg RF, Frost PH, Seymour AB, Kane JP, Malloy MJ. Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease. Am J Cardiol. 2011 Aug 1;108(3):360-6. doi: 10.1016/j.amjcard.2011.03.054. PubMed PMID: 21757044

.
Deedwania P. ACP Journal Club. Review: rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes. Ann Intern Med. 2011 Aug 16;155(4):JC2-12. doi: 10.7326/0003-4819-155-4-201108160-02012. PubMed PMID: 21844545

.
Roy B, Pawar PP, Desai RV, Fonarow GC, Mujib M, Zhang Y, Feller MA, Ovalle F, Aban IB, Love TE, Iskandrian AE, Deedwania P, Ahmed A. A propensity-matched study of the association of diabetes mellitus with incident heart failure and mortality among community-dwelling older adults. Am J Cardiol. 2011 Dec 15;108(12):1747-53. doi: 10.1016/j.amjcard.2011.07.046. Epub 2011 Sep 22. PubMed PMID: 21943936; PubMed Central PMCID: PMC3324944.


Deedwania P, Huang GW. An update on antithrombotic therapy in atrial fibrillation: the role of newer and emergent drugs. Rev Cardiovasc Med. 2012;13(2-3):e89-104. Review. PubMed PMID: 23160166.


Gupta R, Deedwania PC, Sharma K, Gupta A, Guptha S, Achari V, Asirvatham AJ, Bhansali A, Gupta B, Gupta S, Jali MV, Mahanta TG, Maheshwari A, Saboo B, Singh J, Gupta R. Association of educational, occupational and socioeconomic status with cardiovascular risk factors in Asian Indians: a cross-sectional study. PLoS One. 2012;7(8):e44098. doi: 10.1371/journal.pone.0044098. Epub 2012 Aug 29. PubMed PMID: 22952886; PubMed Central PMCID: PMC3430674.


Deedwania P, Huang GW. An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillation. Core Evid. 2012;7:49-59. doi: 10.2147/CE.S25637. Epub 2012 Jul 9. PubMed PMID: 22826692; PubMed Central PMCID: PMC3402013.


Qian F, Ling FS, Deedwania P, Hernandez AF, Fonarow GC, Cannon CP, Peterson ED, Peacock WF, Kaltenbach LA, Laskey WK, Schwamm LH, Bhatt DL; Get With The Guidelines Steering Committee and Investigators. Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease program. Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):126-33. doi: 10.1161/CIRCOUTCOMES.111.961987. Epub 2012 Jan 10. PubMed PMID: 22235068.


Luke MM, Berger K, Rowland CM, Catanese JJ, Tong CH, Ross DA, Garcia V, Kuhlenbaeumer G, Ringelstein EB, Pullinger CR, Malloy MJ, Deedwania P, Ellis SG, Kane JP, Devlin JJ, Lalouschek W, Mannhalter C. Polymorphisms and noncardioembolic stroke in three case-control studies. Cerebrovasc Dis. 2012;33(1):80-5. doi: 10.1159/000333444. Epub 2011 Dec 1. PubMed PMID: 22134093.


Ahmed MI, Mujib M, Desai RV, Feller MA, Daniel C, Aban IB, Love TE, Deedwania P, Pitt B, Aronow WS, Ahmed A. Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched study. Int J Cardiol. 2012 Jan 26;154(2):128-33. doi: 10.1016/j.ijcard.2010.09.006. Epub 2010 Oct 14. PubMed PMID: 20947188; PubMed Central PMCID: PMC3116091.


Arsenault BJ, Boekholdt SM, Hovingh GK, Hyde CL, DeMicco DA, Chatterjee A, Barter P, Deedwania P, Waters DD, LaRosa JC, Pedersen TR, Kastelein JJ; TNT and IDEAL Investigators. The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies. Circ Cardiovasc Genet. 2012 Feb 1;5(1):51-7. doi: 10.1161/CIRCGENETICS.111.960252. Epub 2011 Dec 1. PubMed PMID: 22135385.


Meyer P, Desai RV, Mujib M, Feller MA, Adamopoulos C, Banach M, Lainscak M, Aban I, White M, Aronow WS, Deedwania P, Iskandrian AE, Ahmed A. Right ventricular ejection fraction <20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients. Int J Cardiol. 2012 Feb 23;155(1):120-5. doi: 10.1016/j.ijcard.2011.05.046. Epub 2011 Jun 12. PubMed PMID: 21664707; PubMed Central PMCID: PMC3640328.


Mora S, Wenger NK, Demicco DA, Breazna A, Boekholdt SM, Arsenault BJ, Deedwania P, Kastelein JJ, Waters DD. Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study. Circulation. 2012 Apr 24;125(16):1979-87. doi: 10.1161/CIRCULATIONAHA.111.088591. Epub 2012 Mar 29. PubMed PMID: 22461416; PubMed Central PMCID: PMC3338158.


Gupta R, Guptha S, Sharma KK, Gupta A, Deedwania P. Regional variations in cardiovascular risk factors in India: India heart watch. World J Cardiol. 2012 Apr 26;4(4):112-20. doi: 10.4330/wjc.v4.i4.112. PubMed PMID: 22558490; PubMed Central PMCID: PMC3342579.


Mujib M, Desai RV, Ahmed MI, Guichard JL, Feller MA, Ekundayo OJ, Deedwania P, Ali M, Aban IB, Love TE, White M, Aronow WS, Rahimtoola SH, Bonow RO, Ahmed A. Rheumatic heart disease and risk of incident heart failure among community-dwelling older adults: a prospective cohort study. Ann Med. 2012 May;44(3):253-61. doi: 10.3109/07853890.2010.530685. Epub 2011 Jan 24. PubMed PMID: 21254894; PubMed Central PMCID: PMC3116996.


Ho JE, Waters DD, Kean A, Wilson DJ, Demicco DA, Breazna A, Wun CC, Deedwania PC, Khush KK; TNT Investigators. Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study). Am J Cardiol. 2012 Jun 15;109 (12):1761-6. doi: 10.1016/j.amjcard.2012.02.019. Epub 2012 Mar 28. PubMed PMID: 22459310.


Deedwania PC, Zappe DH, Egan BM, Purkayastha D, Samuel R, Sowers JR. Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide? J Clin Hypertens (Greenwich). 2012 Jul;14(7):415-21. doi: 10.1111/j.1751-7176.2012.00635.x. Epub 2012 Apr 26. PubMed PMID: 22747613.


Rathi S, Deedwania PC. The epidemiology and pathophysiology of heart failure. Med Clin North Am. 2012 Sep;96(5):881-90. doi: 10.1016/j.mcna.2012.07.011. Review. PubMed PMID:


Deedwania PC, Carbajal E. Evidence-based therapy for heart failure. Med Clin North Am. 2012 Sep;96(5):915-31. doi: 10.1016/j.mcna.2012.07.010. Review. PubMed PMID: 22980055.
Lardizabal JA, Deedwania PC. Atrial fibrillation in heart failure. Med Clin North Am. 2012 Sep;96(5):987-1000. doi: 10.1016/j.mcna.2012.07.007. Epub 2012 Aug Review. PubMed PMID: 22980060.


Deedwania PC. Heart failure: a common and complex clinical syndrome. Med Clin North Am. 2012 Sep;96(5):xi-xii. doi: 10.1016/j.mcna.2012.08.001. PubMed PMID: 22980062.


Bangalore S, Steg G, Deedwania P, Crowley K, Eagle KA, Goto S, Ohman EM, Cannon CP, Smith SC, Zeymer U, Hoffman EB, Messerli FH, Bhatt DL; REACH Registry Investigators. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012 Oct 3;308(13):1340-9. doi: 10.1001/jama.2012.12559. PubMed PMID: 23032550.


Deedwania P, Ahmed A. Prediabetes and the risk of diabetes. Lancet. 2012 Oct 6;380(9849):1225; author reply 1226. doi: 10.1016/S0140-6736(12)61705-X. PubMed PMID: 23040849.


Gupta R, Guptha S, Gupta VP, Agrawal A, Gaur K, Deedwania PC. Twenty-year trends in cardiovascular risk factors in India and influence of educational status. Eur J Prev Cardiol. 2012 Dec;19(6):1258-71. doi:10.1177/1741826711424567. Epub 2011 Sep 26. PubMed PMID: 21947630.


Deedwania PC. Ivabradine in heart failure: hope or hype? Am J Cardiovasc Drugs. 2012 Dec 1;12(6):357-9. doi: 10.2165/11642100-000000000-00000. PubMed PMID: 23181943.


Gupta R, Deedwania PC, Achari V, Bhansali A, Gupta BK, Gupta A, Mahanta TG, Asirvatham AJ, Gupta S, Maheshwari A, Saboo B, Jali MV, Singh J, Guptha S, Sharma KK. Normotension, prehypertension, and hypertension in urban middle-class subjects in India: prevalence, awareness, treatment, and control. Am J Hypertens. 013 Jan;26(1):83-94. doi: 10.1093/ajh/hps013. PubMed PMID: 23382331.


Deedwania P. Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure. Drugs. 2013 Sep; 73(14):1569-86. PMID: 24065301.


Bangalore S, Fayyad R, Laskey R, Demicco DA, Deedwania P, Kostis JB, Messerli FH. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease. Am J Med. 2014 Jan; 127(1):71-81.e1. PMID: 24210549


Kiel RG, Deedwania P. Medical treatment of hypertension in patients with heart failure with preserved ejection fraction. Curr Cardiol Rep. 2013 Dec; 15(12):428. PMID: 24162922


Ahmed A, Bourge RC, Fonarow GC, Patel K, Morgan CJ, Fleg JL, Aban IB, Love TE, Yancy CW, Deedwania P, van Veldhuisen DJ, Filippatos GS, Anker SD, Allman RM. Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure. Am J Med. 2014 Jan; 127(1):61-70. PMID: 24257326.


Deedwania PC. Statins in chronic kidney disease: cardiovascular risk and kidney function. Postgrad Med. 2014 Jan; 126(1):29-36. PMID: 24393749


Guptha S, Gupta R, Deedwania P, Bhansali A, Maheshwari A, Gupta A, Gupta B, Saboo B, Singh J, Achari V, Sharma KK. Cholesterol lipoproteins and prevalence of dyslipidemias in urban Asian Indians: a cross sectional study. Indian Heart J. 2014 May-Jun; 66(3):280-8. PMID: 24973832.


Inampudi C, Parvataneni S, Morgan CJ, Deedwania P, Fonarow GC, Sanders PW, Prabhu SD, Butler J, Forman DE, Aronow WS, Allman RM, Ahmed A. Spironolactone use and higher hospital readmission for Medicare beneficiaries with heart failure, left ventricular ejection fraction <45%, and estimated glomerular filtration rate <45 ml/min/1.73 m(2.). Am J Cardiol. 2014 Jul 1; 114(1):79-82. PMID: 24846806.


Bajaj NS, Bhatia V, Sanam K, Ather S, Hashim T, Morgan C, Fonarow GC, Nanda NC, Prabhu SD, Adamopoulos C, Kheirbek R, Aronow WS, Fletcher RD, Anker SD, Ahmed A, Deedwania P. Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults. Am J Cardiol. 2014 Sep 15; 114(6):909-13. PMID: 25208562


White M, Patel K, Caldentey G, Deedwania P, Kheirbek R, Fletcher RD, Aban IB, Lo A, Aronow WS, Fonarow GC, Anker SD, Ahmed A. Racial differences in mortality in patients with advanced systolic heart failure: Potential role of right ventricular ejection fraction. Int J Cardiol. 2014 Nov 15; 177(1):255-60. PMID: 25499389


Patel K, Fonarow GC, Ahmed M, Morgan C, Kilgore M, Love TE, Deedwania P, Aronow WS, Anker SD, Ahmed A. Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2014 Nov; 7(6):945-52. PMID: 25296862


Böhm M, Reil JC, Deedwania P, Kim JB, Borer JS. Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease. Am J Med. 2015 Mar; 128(3):219-28. PMID: 25447617


Kumbhani DJ, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Deedwania P, Grau-Sepulveda M, Schwamm LH, Bhatt DL. Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease. Am J Med. 2015 Apr; 128(4):426.e1-9. PMID: 25433302


Desai RV, Guichard JL, Mujib M, Ahmed MI, Feller MA, Fonarow GC, Meyer P, Iskandrian AE, Bogaard HJ, White M, Aban IB, Aronow WS, Deedwania P, Waagstein F, Ahmed A. Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving β-blockers: insights from the BEST trial. Int J Cardiol. 2013 Feb 10;163(1):61-7. doi:10.1016/j.ijcard.2011.05.051. Epub 2011 Jun 24. PubMed PMID: 21704392; PubMed Central PMCID: PMC3395778.


Deedwania P, Shea J, Chen W, Brener L. Effects of add-on nebivolol on blood pressure and glucose parameters in hypertensive patients with prediabetes. J Clin Hypertens (Greenwich). 2013 Apr;15(4):270-8. doi: 10.1111/jch.12071. Epub 2013 Feb 1. PubMed PMID: 23551727.


Deedwania PC. New oral anticoagulants in elderly patients with atrial fibrillation. Am J Med. 2013 Apr;126(4):289-96. doi: 10.1016/j.amjmed.2012.10.012. Epub 2013 Jan 28. Review. PubMed PMID: 23369212.


Deedwania P. Diabetes, cardiovascular disease, and ethnicity. J Am Coll Cardiol. 2013 Apr 30;61(17):1787-9. doi: 10.1016/j.jacc.2013.01.059. Epub 2013 Feb 28. PubMed PMID: 23500320

.
Bethel MA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Kahn SE, Levitt NS, McMurray JJ, Califf RM, Raptis SA, Thomas L, Sun JL, Haffner SM. A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk. Am J Cardiol. 2013 Jul 15;112 (2):231-7. doi: 10.1016/j.amjcard.2013.03.019. Epub 2013 Apr 19. PubMed PMID: 23608615.


Deedwania P. Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure. Drugs. 2013 Sep; 73 (14):1569-86. doi: 10.1007/s40265-013-0117-0. Review. PubMed PMID: 24065301; PubMed Central PMCID: PMC3786091.


Deedwania P, Patel K, Fonarow GC, Desai RV, Zhang Y, Feller MA, Ovalle F, Love TE, Aban IB, Mujib M, Ahmed MI, Anker SD, Ahmed A. Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study. Int J Cardiol. 2013 Oct 9; 168 (4):3616-22. doi: 10.1016/j.ijcard.2013.05.038. Epub 2013 May 31. PubMed PMID: 23731526; PubMed Central PMCID: PMC3939803.


Kiel RG, Deedwania P. Medical treatment of hypertension in patients with heart failure with preserved ejection fraction. Curr Cardiol Rep. 2013 Dec; 15 (12):428. doi: 10.1007/s11886-013-0428-5. Review. PubMed PMID: 24162922.


Deedwania PC. Statins in chronic kidney disease: cardiovascular risk and kidney function. Postgrad Med. 2014 Jan; 126 (1):29-36. doi: 10.3810/pgm.2014.01.2722. Review. PubMed PMID: 24393749.


Gupta A, Gupta R, Sharma KK, Lodha S, Achari V, Asirvatham AJ, Bhansali A, Gupta B, Gupta S, Jali MV, Mahanta TG, Maheshwari A, Saboo B, Singh J, Deedwania PC. Prevalence of diabetes and cardiovascular risk factors in middle-class urban participants in India. BMJ Open Diabetes Res Care. 2014; 2(1):e000048. PMID: 25489485.


Bangalore S, Fayyad R, Laskey R, Demicco DA, Deedwania P, Kostis JB, Messerli FH; Treating to New Targets Steering Committee and Investigators. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease. Am J Med. 2014 Jan;127 (1):71-81.e1. doi: 10.1016/j.amjmed.2013.07.038. Epub 2013 Nov 7. PubMed PMID: 24210549

.
Arsenault BJ, Barter P, DeMicco DA, Bao W, Preston GM, LaRosa JC, Grundy SM, Deedwania P, Greten H, Wenger NK, Shepherd J, Waters DD, Kastelein JJ. Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers. PLoS One. 2014; 9(12):e114519. PMID: 25531109.


Ahmed A, Bourge RC, Fonarow GC, Patel K, Morgan CJ, Fleg JL, Aban IB, Love TE, Yancy CW, Deedwania P, van Veldhuisen DJ, Filippatos GS, Anker SD, Allman RM. Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure. Am J Med. 2014 Jan;127(1):61-70. doi: 10.1016/j.amjmed.2013.08.027. Epub 2013 Nov 18. PubMed PMID: 24257326; PubMed Central PMCID: PMC3929967.


Guptha S, Gupta R, Deedwania P, Bhansali A, Maheshwari A, Gupta A, Gupta B, Saboo B, Singh J, Achari V, Sharma KK. Cholesterol lipoproteins and prevalence of dyslipidemias in urban Asian Indians: a cross sectional study. Indian Heart J. 2014 May-Jun;66(3):280-8. doi: 10.1016/j.ihj.2014.03.005. Epub 2014 Apr 16. PubMed PMID: 24973832; PubMed Central PMCID: PMC4121768.


Inampudi C, Parvataneni S, Morgan CJ, Deedwania P, Fonarow GC, Sanders PW, Prabhu SD, Butler J, Forman DE, Aronow WS, Allman RM, Ahmed A. Spironolactone use and higher hospital readmission for Medicare beneficiaries with heart failure, left ventricular ejection fraction <45%, and estimated glomerular filtration rate <45 ml/min/1.73 m(2.). Am J Cardiol. 2014 Jul 1;114(1):79-82. doi: 10.1016/j.amjcard.2014.03.062. Epub 2014 Apr 18. PubMed PMID: 24846806.
Bangalore S, Fayyad R, Laskey R, DeMicco D, Deedwania P, Kostis JB, Messerli FH; Treating to New Targets Steering Committee and Investigators. Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trial. Eur Heart J. 2014 Jul 14;35(27):1801-8. doi:10.1093/eurheartj/eht315. Epub 2013 Aug 29. PubMed PMID: 23990605.


Inampudi C, Parvataneni S, Morgan CJ, Deedwania P, Fonarow GC, Prabhu SD, Butler J, Aronow WS, Sanders PW, Allman RM, Ahmed A. Chronic kidney disease and higher risk of 30-day all-cause readmissions in heart failure: findings from a propensity-matched study. J Card Fail. 2014 Aug;20(8 Suppl):S56. doi: 10.1016/j.cardfail.2014.06.159. PubMed PMID: 25107151.


Inampudi C, Parvataneni S, Morgan CJ, Deedwania P, Fonarow GC, Prabhu SD, Butler J, Zile MR, Aronow WS, Sanders PW, Allman RM, Ahmed A. Lack of association between spironolactone use and 30-day all-cause readmission in hospitalized medicare beneficiaries with systolic heart failure eligible for spironolactone therapy. J Card Fail. 2014 Aug;20(8 Suppl):S58. doi: 10.1016/j.cardfail.2014.06.162. PubMed PMID: 25107155.


Inampudi C, Deedwania P, Fonarow GC, Sanders PW, Aronow WS, Ahmed A. Reply. Am J Cardiol. 2015 Jan 1; 115(1):156. PMID: 25454018


Bhatia V, Bajaj NS, Sanam K, Hashim T, Morgan CJ, Prabhu SD, Fonarow GC, Deedwania P, Butler J, Carson P, Love TE, Kheirbek R, Aronow WS, Anker SD, Waagstein F, Fletcher R, Allman RM, Ahmed A. Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure. Am J Med. 2015 Jul; 128(7):715-21. PMID: 25554369


Jones LG, Sin MK, Hage FG, Kheirbek RE, Morgan CJ, Zile MR, Wu WC, Deedwania P, Fonarow GC, Aronow WS, Prabhu SD, Fletcher RD, Ahmed A, Allman RM. Characteristics and Outcomes of Patients With Advanced Chronic Systolic Heart Failure Receiving Care at the Veterans Affairs Versus Other Hospitals: Insights From the Beta-blocker Evaluation of Survival Trial (BEST). Circ Heart Fail. 2015 Jan; 8(1):17-24. PMID: 25480782.


Deedwania PC. Management of Patients With Stable Angina and Type 2 Diabetes. Rev Cardiovasc Med. 2015; 16(2):105-13. PMID: 26198557


Deedwania P. Gaps in guideline implementation: acause for concern, time for action. J Am Coll Cardiol. 2015 Jan 27; 65(3):278-80. PMID: 25614425


Ahmed AA, Patel K, Nyaku MA, Kheirbek RE, Bittner V, Fonarow GC, Filippatos GS, Morgan CJ, Aban IB, Mujib M, Desai RV, Allman RM, White M, Deedwania P, Howard G, Bonow RO, Fletcher RD, Aronow WS, Ahmed A. Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking. Circ Heart Fail. 2015 Jul; 8(4):694-701. PMID: 26038535


Acharya T, Deedwania P. An evidence-based review of edoxaban and its role in stroke prevention in patients with nonvalvular atrial fibrillation. Core Evid. 2015; 10:63-73. PMID: 26019695.


Anker SD, Kosiborod M, Zannad F, Piña IL, McCullough PA, Filippatos G, van der Meer P, Ponikowski P, Rasmussen HS, Lavin PT, Singh B, Yang A, Deedwania P. Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial. Eur J Heart Fail. 2015 Oct; 17(10):1050-6. PMID: 26011677


Aftab W, Gazallo J, Motabar A, Varadrajan P, Deedwania PC, Pai RG. Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation. Int J Angiol. 2015 Jun; 24(2):105-12. PMID: 26060381.


Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, Vafiadis DK. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Circulation. 2015 Aug 25; 132(8):691-718. PMID: 26246173


Gupta R, Sharma KK, Gupta BK, Gupta A, Saboo B, Maheshwari A, Mahanta T, Deedwania PC. Geographic epidemiology of cardiometabolic risk factors in middle class urban residents in India: cross-sectional study. J Glob Health. 2015 Jun; 5(1):010411. PMID: 25969733.


Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, Vafiadis DK. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care. 2015 Sep; 38(9):1777-803. PMID: 26246459


Ahmed AA, Patel K, Feller M, Bittner V, Fonarow GC, Filippatos GS, Morgan CJ, Aban IB, Mujib M, Desai RV, Allman RM, White M, Deedwania P, Howard G, Bonow RO, Aronow WS, Ahmed A. Risk of incident heart failure and death after prolonged smoking cessation among older former smokers: Role of amount and duration of prior smoking. Circulation – Heart Failure. 2015; 8 (4): 694–701. PMCID: pending. PMID: 26038535


Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, La Forge R, Daniels SR, Wilson DP, Morris PB, Wild RA, Grundy SM, Daviglus M, Ferdinand KC, Vijayaraghavan K, Deedwania PC, Aberg JA, Liao KP, McKenney JM, Ross JL, Braun LT, Ito MK, Bays HE, Brown WV. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. J Clin Lipidol. 2015 Nov-Dec; 9(6 Suppl):S1-S122.e1. PMID: 26699442

 

Bhatia V, Bajaj NS, Sanam K, Hashim T, Morgan CJ, Prabhu SD, Fonarow GC,
Deedwania P, Butler J, Carson P, Love TE, Kheirbek R, Aronow WS, Anker SD,
Waagstein F, Fletcher R, Allman RM, Ahmed A. Beta-blocker Use and 30-day
All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure. Am J Med. 2015 Jul;128(7):715-21. doi: 10.1016/j.amjmed.2014.11.036. Epub 2014 Dec 30.PubMed PMID: 25554369.

Morris PB, Ference BA, Jahangir E, Feldman DN, Ryan JJ, Bahrami H, El-Chami MF, Bhakta S, Winchester DE, Al-Mallah MH, Sanchez Shields M, Deedwania P, Mehta LS, Phan BA, Benowitz NL. Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology. J Am Coll Cardiol. 2015 Sep 22; 66(12):1378-91. PMID: 26383726


Acharya T, Tringali S, Bhullar M, Nalbandyan M, Ilineni VK, Carbajal E, Deedwania P. Frequent Atrial Premature Complexes and Their Association With Risk of Atrial Fibrillation. Am J Cardiol. 2015 Dec 15; 116(12):1852-7. PMID: 26611122


Kiel RG, Deedwania P. The safety and tolerability of beta blockers in heart failure with reduced ejection fraction: is the current underutilization of this evidence-based therapy justified? Expert Opin Drug Saf. 2015 Dec; 14(12):1855-63. PMID: 26488593


Deedwania PC, Stone PH, Fayyad RS, Laskey RE, Wilson DJ. Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial. Drugs Aging. 2015 Dec; 32(12):1055-65. PMID: 26625880.


Deedwania P, Acharya T. Is Increased Use of Mechanical Circulatory Support Devices Justified?: A Cause for Concern. JAMA Intern Med. 2015 Dec 1; 175(12):1982-3. PMID: 26523417


Deedwania PC, Shepherd J, Breazna A, DeMicco DA. Effect of high-dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the Treating to New Targets (TNT) study. Diabetes Obes Metab. 2016 Jan; 18(1):56-63. PMID: 26434404


Shepherd J, Breazna A, Deedwania PC, LaRosa JC, Wenger NK, Messig M, Wilson DJ. Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study). Am J Cardiol. 2016 Apr 15; 117(8):1199-205. PMID: 26940556

 

Deedwania P, Acharya T. Mechanical Circulatory Support and Rationale for Future Research-Reply. JAMA Intern Med. 2016 May 1; 176(5):715-6. PMID: 27